03 - 04 December, 2019 | Millennium Gloucester Hotel London Kensington, London, United Kingdom

Conference Day 2

9:00 am - 9:25 am Registration and Coffee

9:30 am - 9:40 am Chaiman's Recap of Day One

Dr Paul Unwin, Chairman at Additive Manufacturing UK Strategy Steering Group

Dr Paul Unwin

Additive Manufacturing UK Strategy Steering Group

9:40 am - 10:20 am Challenges of Adopting Additive Manufacturing in Highly Regulated Industries and Current Best Practice

  • Look at the wide range of industries that AM is being applied in, such as the highly regulated aerospace sector 
  • Understand the learning that early adopters of, in particular, metal AM have had to complete to overcome the challenges presented by this approach to manufacture
  • Apply best practice that has been established as a result of this early work and understand how it’s widely applicable to companies working in other highly regulated sectors, such as medical
David Brackett, Technology Manager – Additive Manufacturing at Manufacturing Technology Centre (MTC)

David Brackett

Technology Manager – Additive Manufacturing
Manufacturing Technology Centre (MTC)

10:20 am - 11:00 am Creating a 3D Printing Ecosystem to Transform Health for Humanity

  • Discover how the Johnson & Johnson 3D Printing Center of Excellence (CoE) is an innovation hub and how it leverages the company’s breadth and scale to evolve the way Johnson & Johnson creates and delivers healthcare solutions
  • Discuss the CoE application areas including surgical tooling, metal and polymer custom implants, personalised medicines, printed electronics and sensors, bioprinting and tissue regenerative technologies
  • Dive into Point-of-Care Solutions: an entirely new business model incorporating personalised solutions and services to provide real-time, on-demand connectivity at key patient touch points
  • Explore the scope of global collaborations of CoE with technology companies, academic institutions, hospitals and government bodies to leverage expertise and advance its product platforms

Sam Onukuri, Head of 3D Printing Center of Excellence at Johnson & Johnson

Sam Onukuri

Head of 3D Printing Center of Excellence
Johnson & Johnson

11:00 am - 11:30 am Networking Coffee Break

11:30 am - 12:10 pm An Example of Using the Additive Manufacturing Guidance from the U.S. Food and Drug Administration

  • Review the U.S. FDA 2017 Guidance Document “Technical Considerations for Additive Manufactured Medical Devices” which is intended to help medical device stakeholders with AM aspects of their pre-market submissions
  • Convey how a sponsor could use the U.S. FDA 2017 AM Guidance Document for a hypothetical 510(k) pre-market submission using a fictitious patient matched bone plate system
  • Discuss considerations such as design, software workflow, material control, post-processing, and final testing
  • Focus primarily on the AM aspect of a fictitious 510(k) premarket submission

Daniel Porter, Mechanical Engineer at FDA

Daniel Porter

Mechanical Engineer

12:10 pm - 12:50 pm 3D Printed Medical Devices that Optimise Soft Tissue Adhesion & Integration

  • Discuss attaching and integrating medical devices with host soft tissue and the methods of fixation used
  • Explore the reliance on chemical-based adhesives or mechanical methods of fixation (sutures or staples)
  • Outline how 3D printing has been used to advance metallic microneedle and soft-tissue interfacing polymeric devices towards clinical translation

Dr Eoin O’Cearbhaill BE PhD, Lecturer in Biomedical Engineering at University College Dublin

Dr Eoin O’Cearbhaill BE PhD

Lecturer in Biomedical Engineering
University College Dublin

12:50 pm - 1:50 pm Networking Lunch

1:50 pm - 2:30 pm The MDR 2017/247 and its Effects on Additive Manufacturing Techniques and Devices

  • Discuss MDR requirements for additive manufacturers and their products
  • Engage in an overview of the status quo of additive manufacturing standardisation
  • Review best practice use cases in qualification of additive manufacturing facilities and processes
Gregor Reischle, Head of Additive Manufacturing at TÜV SÜD

Gregor Reischle

Head of Additive Manufacturing

2:30 pm - 3:10 pm Safe Use of Additive Manufacturing in the Workplace

  • Does the use of AM present new health and safety risks in the workplace?
  • Which aspects of AM 3D printing present risks for health and safety?
  • Review case studies of AM printing and health and safety, including metal powder AM for aerospace and fused polymer filament desktop 3D printing

Gareth Evans, Principal Scientist and Professional Lead for Health at HSE Science and Research Centre

Gareth Evans

Principal Scientist and Professional Lead for Health
HSE Science and Research Centre

3:10 pm - 3:50 pm Combined Additive Manufacturing for Medical Device Prototyping

  • Review the design parameters for different AM technologies
  • Discuss post-print considerations such as cleaning and assembly 
  • Consider the limits of using AM technologies in medical device development 

Alexander Berry, Director at Sutrue

Alexander Berry


·         Discuss the contributions of additive manufacturing to industry 4.0
·         Review the recent advances on material science, process development, and enhancements on design consideration
·         What clinical benefit will this have?
Dr Paul Unwin, Chairman at Additive Manufacturing UK Strategy Steering Group

Dr Paul Unwin

Additive Manufacturing UK Strategy Steering Group

Afonso Nogueira, Owner at Hypermetal – Metal Additive Manufacturing

Afonso Nogueira

Hypermetal – Metal Additive Manufacturing

Nia Dokova, Director at Sutrue

Nia Dokova


4:30 pm - 4:40 pm Chairman's Closing Summary and End of Day 2

Dr Paul Unwin, Chairman at Additive Manufacturing UK Strategy Steering Group

Dr Paul Unwin

Additive Manufacturing UK Strategy Steering Group